Table 2 Characteristics of the Mapou cohort population tested in 2000 and 2001
| Â | Â | 2000 | Â | Â | Â | 2001 | Â | Â | Â | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
Variable | N tested | N (%) positive | Mean | SD | N tested | N (%) positive | Mean | SD | p-value | ||
Gender (female) | 161 | 87 | (54.0%) | - | 0.50 | - | - | Â | - | - | - |
Age (years) | 160 | - | 24.7 | 19.52 | - | - | - | - | - | ||
Antigen + | 160 | 24 | (15.0%) | - | 0.36 | 161 | 14 | (8.7%) | - | 0.28 | 0.004 |
Microfilaremic | 161 | 1 | (0.6%) | 1* | 0.08 | 160 | 1 | (0.6%) | 1* | 0.08 | 1.0 |
Drug coverage | 160 | 126 | (78.8%) | - | 0.41 | N/A | N/A | - | N/A | - | |
Antifilarial IgG1 | 161 | 94 | (58.4%) | 122.7 | 182.5 | 161 | 85 | 52.8% | 99.0 | 146.9 | 0.11 |
Antifilarial IgG4 | 161 | 125 | (77.6%) | 104.8 | 155.4 | 161 | 117 | 72.7% | 102.1 | 215.6 | 0.052 |